Severe acute respiratory syndrome coronaviruses contributing to mitochondrial dysfunction: Implications for post-COVID complications
- PMID: 36690315
- PMCID: PMC9854144
- DOI: 10.1016/j.mito.2023.01.005
Severe acute respiratory syndrome coronaviruses contributing to mitochondrial dysfunction: Implications for post-COVID complications
Abstract
Mitochondria play a central role in oxidative phosphorylation (OXPHOS), bioenergetics linked with ATP production, fatty acids biosynthesis, calcium signaling, cell cycle regulation, apoptosis, and innate immune response. Severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infection manipulates the host cellular machinery for its survival and replication in the host cell. The infectiaon causes perturbed the cellular metabolism that favours viral replication leading to mitochondrial dysfunction and chronic inflammation. By localizing to the mitochondria, SARS CoV proteins increase reactive oxygen species (ROS) levels, perturbation of Ca2+ signaling, changes in mtDNA copy number, mitochondrial membrane potential (MMP), mitochondrial mass, and induction of mitophagy. These proteins also influence the fusion and fission kinetics, size, structure, and distribution of mitochondria in the infected host cells. This results in compromised bioenergetics, altered metabolism, and innate immune signaling, and hence can be a key player in determining the outcome of SARS-CoV infection. SARS-CoV infection contributes to stress and activates apoptotic pathways. This review summarizes how mitochondrial function and dynamics are affected by SARS-CoV and how the mitochondria-SARS-CoV interaction benefits viral survival and growth by evading innate host immunity. We also highlight how the SARS-CoV-mediated mitochondrial dysfunction contributes to post-COVID complications. Besides, a discussion on targeting virus-mitochondria interactions as a therapeutic strategy is presented.
Keywords: CoV; Mitochondria; Mitochondrial localization signal; ROS; SARS; Virus.
Copyright © 2023 Elsevier B.V. and Mitochondria Research Society. All rights reserved. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures


Similar articles
-
Post-Acute Sequelae and Mitochondrial Aberration in SARS-CoV-2 Infection.Int J Mol Sci. 2024 Aug 21;25(16):9050. doi: 10.3390/ijms25169050. Int J Mol Sci. 2024. PMID: 39201736 Free PMC article. Review.
-
Pathophysiological involvement of host mitochondria in SARS-CoV-2 infection that causes COVID-19: a comprehensive evidential insight.Mol Cell Biochem. 2023 Jun;478(6):1325-1343. doi: 10.1007/s11010-022-04593-z. Epub 2022 Oct 29. Mol Cell Biochem. 2023. PMID: 36308668 Free PMC article. Review.
-
Mitochondrial DNA and TLR9 activation contribute to SARS-CoV-2-induced endothelial cell damage.Vascul Pharmacol. 2022 Feb;142:106946. doi: 10.1016/j.vph.2021.106946. Epub 2021 Nov 25. Vascul Pharmacol. 2022. PMID: 34838735 Free PMC article.
-
SARS-CoV-2 and other coronaviruses negatively influence mitochondrial quality control: beneficial effects of melatonin.Pharmacol Ther. 2021 Aug;224:107825. doi: 10.1016/j.pharmthera.2021.107825. Epub 2021 Mar 1. Pharmacol Ther. 2021. PMID: 33662449 Free PMC article. Review.
-
Mitochondrial antioxidants abate SARS-COV-2 pathology in mice.Proc Natl Acad Sci U S A. 2024 Jul 23;121(30):e2321972121. doi: 10.1073/pnas.2321972121. Epub 2024 Jul 15. Proc Natl Acad Sci U S A. 2024. PMID: 39008677 Free PMC article.
Cited by
-
Post-Acute Sequelae and Mitochondrial Aberration in SARS-CoV-2 Infection.Int J Mol Sci. 2024 Aug 21;25(16):9050. doi: 10.3390/ijms25169050. Int J Mol Sci. 2024. PMID: 39201736 Free PMC article. Review.
-
Analysis of the mechanism of berberine against stomach carcinoma based on network pharmacology and experimental validation.Transl Cancer Res. 2024 Sep 30;13(9):4593-4607. doi: 10.21037/tcr-24-668. Epub 2024 Sep 27. Transl Cancer Res. 2024. PMID: 39430861 Free PMC article.
-
Viral mitochondriopathy in COVID-19.Redox Biol. 2025 Jul 12;85:103766. doi: 10.1016/j.redox.2025.103766. Online ahead of print. Redox Biol. 2025. PMID: 40680383 Free PMC article. Review.
-
Attenuating mitochondrial dysfunction-derived reactive oxygen species and reducing inflammation: the potential of Daphnetin in the viral pneumonia crisis.Front Pharmacol. 2024 Oct 18;15:1477680. doi: 10.3389/fphar.2024.1477680. eCollection 2024. Front Pharmacol. 2024. PMID: 39494349 Free PMC article. Review.
-
Novel Mutations in the Non-Structure Protein 2 of SARS-CoV-2.Mediterr J Hematol Infect Dis. 2023 Nov 1;15(1):e2023059. doi: 10.4084/MJHID.2023.059. eCollection 2023. Mediterr J Hematol Infect Dis. 2023. PMID: 38028396 Free PMC article.
References
-
- Almagro Armenteros J.J., Tsirigos K.D., Sønderby C.K., Petersen T.N., Winther O., Brunak S., von Heijne G., Nielsen H. SignalP 5.0 improves signal peptide predictions using deep neural networks. Nat. Biotechnol. 2019;37:420–423. - PubMed
-
- Archer S.L., Dasgupta A., Chen K.H., Wu D., Baid K., Mamatis J.E., Gonzalez V., Read A., Bentley R.E., Martin A.Y., Mewburn J.D., Dunham-Snary K.J., Evans G.A., Levy G., Jones O., Al-Qazazi R., Ring B., Alizadeh E., Hindmarch C.C., Rossi J., Lima P.D., Falzarano D., Banerjee A., Colpitts C.C. SARS-CoV-2 mitochondriopathy in COVID-19 pneumonia exacerbates hypoxemia. Redox Biol. 2022;58 - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous